These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6633616)

  • 61. Metacarpophalangeal length changes in humans during adulthood: a longitudinal study.
    Harris EF; Aksharanugraha K; Behrents RG
    Am J Phys Anthropol; 1992 Mar; 87(3):263-75. PubMed ID: 1562058
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of estrogen dose on postmenopausal bone loss.
    Sheldon AE
    N Engl J Med; 1984 Aug; 311(9):604-5. PubMed ID: 6749241
    [No Abstract]   [Full Text] [Related]  

  • 63. Estrogen therapy.
    Dreisbach RH; Kalman SM
    N Engl J Med; 1969 Jul; 281(2):108-9. PubMed ID: 5784772
    [No Abstract]   [Full Text] [Related]  

  • 64. Periosteal and endosteal surface remodeling in pathologic conditions.
    Dequeker J
    Invest Radiol; 1971; 6(4):260-5. PubMed ID: 5567119
    [No Abstract]   [Full Text] [Related]  

  • 65. Radiological patterns of cortical bone modelling in women with chronic liver disease.
    Kato Y; Epstein O; Dick R; Sherlock S
    Clin Radiol; 1982 May; 33(3):313-7. PubMed ID: 7075137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Continuing bone expansion and increasing bone loss over a two-decade period in men and women from a total community sample.
    Garn SM; Sullivan TV; Decker SA; Larkin FA; Hawthorne VM
    Am J Hum Biol; 1992; 4(1):57-67. PubMed ID: 28524405
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect on bone of withdrawal of oestrogen therapy.
    Horsman A; Nordin BE; Crilly RG
    Lancet; 1979 Jul; 2(8132):33. PubMed ID: 87899
    [No Abstract]   [Full Text] [Related]  

  • 68. Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.
    Peacock M; Selby P
    Br Med J (Clin Res Ed); 1987 Feb; 294(6569):440. PubMed ID: 3101915
    [No Abstract]   [Full Text] [Related]  

  • 69. Bone mass after withdrawal of oestrogen replacement.
    Christiansen C; Christensen MS; Transbol I
    Lancet; 1981 May; 1(8228):1053-4. PubMed ID: 6112433
    [No Abstract]   [Full Text] [Related]  

  • 70. Brief communication: on the optimum number of metacarpals for roentgenogrammetric measurement.
    Garn SM; Sullivan TV; Decker SA; Hawthorne VM
    Am J Phys Anthropol; 1991 Jun; 85(2):229-32. PubMed ID: 1882985
    [No Abstract]   [Full Text] [Related]  

  • 71. Cortical bone-loss with age.
    Ikkos DG; Katsichtis P; Ntalles K; Velentzas C; Stergiou L
    Lancet; 1971 Nov; 2(7732):1037-8. PubMed ID: 4108095
    [No Abstract]   [Full Text] [Related]  

  • 72. Endosteal-bone formation in estrogen-treated mice.
    URIST MR; BUDY AM; McLEAN FC
    J Bone Joint Surg Am; 1950 Jan; 32A(1):143-62, illust. PubMed ID: 15409259
    [No Abstract]   [Full Text] [Related]  

  • 73. Hormone replacement treatment choices in complete androgen insensitivity syndrome: an audit of an adult clinic.
    Ko JKY; King TFJ; Williams L; Creighton SM; Conway GS
    Endocr Connect; 2017 Aug; 6(6):375-379. PubMed ID: 28615185
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of oral contraceptive different patterns of use on circulating IGF-1 and bone mineral density in healthy premenopausal women.
    Elkazaz AY; Salama K
    Endocrine; 2015 Feb; 48(1):272-8. PubMed ID: 24861474
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estrogen replacement therapy.
    Higgin JR
    Can Fam Physician; 1989 Jun; 35():1375-7. PubMed ID: 21248975
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity.
    Smith EP; Specker B; Korach KS
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):264-72. PubMed ID: 19900547
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women.
    Allali F; El Mansouri L; Abourazzak Fz; Ichchou L; Khazzani H; Bennani L; Abouqal R; Hajjaj-Hassouni N
    BMC Womens Health; 2009 Nov; 9():31. PubMed ID: 19887010
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss.
    Wimalawansa SJ; Grimes JP; Wilson AC; Hoover DR
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3356-64. PubMed ID: 19549739
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Introductory remarks.
    Steinberg KK
    Public Health Rep; 1987 Jul; 102(4 Suppl):125-127. PubMed ID: 19313189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis.
    Zheng Y; Zhou H; Fong-Yee C; Modzelewski JR; Seibel MJ; Dunstan CR
    Clin Exp Metastasis; 2008; 25(5):559-67. PubMed ID: 18421566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.